Mechanism of action: Nitrofurantoin balliculeVisual mnemonic: Nitrofurantoin mascot “Mac bids (on) Night fur”
What it isUrinary antiseptic whose reactive intermediates damage bacterial DNA; uncomplicated lower urinary infection.
Why this oneIt concentrates in urine with little systemic or microbiome exposure, so resistance remains relatively uncommon.
What limits itDo not use for pyelonephritis or bacteremia; poor renal function prevents urinary delivery. Long courses risk lung, liver and nerve toxicity.
Pearls
As effective as TMP/SMX for cystitis, with less E. coli resistance.
Label bars CrCl ≤60; short courses probably safe down to 30.
Avoid at term or in labor: neonatal hemolytic anemia.
G6PD deficiency: hemolysis risk.
Molecular structure: Nitrofurantoin
Nitrofurantoin prescription history
Animated chart of estimated U.S. prescriptions per year, Antibacterials (systemic) (1938–2026). Nitrofurantoin enters in 1953 (estimated).
FDA-approved for
UTIs (~1953)
Principal riskPulmonary toxicity with long-term use; ineffective in pyelonephritis